Obesity is a major threat for patients with T1DM as it triggers a vicious cycle where weight gain leads to insulin resistance which, in turn, leads to increased insulin requirements to achieve glycemic control, resulting in further weight gain. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.